David Protein Says ‘Diet’ Trends Are Over, GLP-1s Upend Markets
David Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Discover yearly leaders among index funds and understand how performance shifts across periods, helping you choose resilient options.
27,113 articlesDavid Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
A new partnership between Palantir and NVIDIA gives government and critical infrastructure clients on-prem AI capabil...
Small-cap stocks have staged a surprising comeback as the market navigates a higher-for-longer rate environment. Inve...
Off the field, Haaland maps a broader financial playbook, backing chess events, an investment firm, and a film role a...
As inflation and retirement pressures mount in 2026, a little-known form lets retirees reset a claim filed early. Her...
Aaron Kirman is expanding beyond brokerage into AI-driven underwriting, crypto-backed loans and new development finan...
Meta CEO Mark Zuckerberg faced lawmakers over under-13 Instagram use and the effectiveness of age checks. The session...
Strategy reports a modest bitcoin purchase from its treasury amid a mid-cap crypto pullback, lifting unrealized losse...
Cardano's price path through 2025 to 2030 hinges on network upgrades and DeFi growth. This analysis outlines base, bu...
APAC startups are accelerating AI adoption as Aspire tracks a 20% rise in AI tool spending among 37,000 SMEs, with co...
Marvell Technology shows signs of narrowing Broadcom's AI revenue lead as data-center demand accelerates, sparking re...
Solana is under renewed selling pressure as negative funding rates persist and on-chain inflows surge. Analysts warn ...